Healthcare Services

Global Osteoarthritis Therapeutics Market Set for Strong Expansion Reaching $13.21 Billion by 2030 at 8.2% CAGR

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Osteoarthritis Therapeutics Market Over The Period 2026–2030?

The osteoarthritis therapeutics market has experienced significant expansion in recent years. This market is forecast to increase from $8.87 billion in 2025 to $9.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. The historical growth of the market can be ascribed to factors including the rising prevalence of osteoarthritis, the world’s aging population, the widespread adoption of NSAIDs and analgesics, the expansion of orthopedic care services, and the availability of established pain management therapies.

The osteoarthritis therapeutics market size is projected to experience substantial growth in the coming years, expected to reach $13.21 billion in 2030, with a compound annual growth rate (CAGR) of 8.2%. This expansion during the forecast period is primarily driven by the increasing development of dmoads, a rising demand for minimally invasive therapies, the ongoing expansion of biologic and cell-based treatments, a growing focus on personalized osteoarthritis care, and increased investment in joint disease research. Furthermore, key trends anticipated in this period include the increasing adoption of disease-modifying osteoarthritis therapies, a rising utilization of regenerative medicine approaches, an intensifying focus on non-opioid pain management, the expansion of injectable and intra-articular treatments, and an enhanced emphasis on early disease intervention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp

Which Major Factors Are Driving The Expansion Of The Osteoarthritis Therapeutics Market?

The growth of the osteoarthritis therapeutics market is expected to be propelled by rising sports injuries. A sports injury refers to any harm or damage sustained during sports or athletic pursuits. These injuries can range from minor to severe in intensity and can affect various parts of the body. The increase in sports injuries is largely driven by greater participation in sports activities and the growing intensity and competitiveness inherent in these activities. Osteoarthritis therapeutics are utilized in sports injuries to manage pain and inflammation and to improve joint function for athletes suffering from joint degeneration. For instance, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia, approximately 62,100 sports injuries led to hospital admission during 2023–24. Furthermore, males accounted for 70% of all hospitalizations (or 43,800 cases), while females represented nearly 30% (or 18,300 cases). Therefore, the increasing number of sports injuries is driving the expansion of the osteoarthritis therapeutics market.

How Is The Osteoarthritis Therapeutics Market Divided Into Its Major Segments?

The osteoarthritis therapeutics market covered in this report is segmented –

1) By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids

2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs

5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products

2) By Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors

3) By Analgesics: Non-Opioid Analgesics, Topical Analgesics

4) By Corticosteroids: Injectable Corticosteroids, Intra-Articular Corticosteroids

What Key Trends Are Influencing The Development Of The Osteoarthritis Therapeutics Market?

Major companies operating in the osteoarthritis therapeutics market are concentrating on developing innovative solutions, such as novel innovations for tissue regeneration in osteoarthritis. This process refers to the repair or replacement of damaged cartilage and joint tissues, aimed at restoring normal function and alleviating pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, initiated the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). The NITRO program, spearheaded by ARPA-H, is dedicated to developing cutting-edge injectable therapies that encourage cartilage repair by leveraging biological pathways similar to those active during embryonic development. Key features encompass a collaborative multimodal approach among research teams and advanced testing techniques like “joint-on-a-chip” platforms to replicate joint environments, all with the objective of creating regenerative solutions that address the underlying causes of osteoarthritis.

Who Are The Prominent Organizations Shaping The Osteoarthritis Therapeutics Market?

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Galapagos NV, Regeneron Pharmaceuticals Inc., Samumed LLC, Kolon Life Science Inc., Horizon Therapeutics plc

Read the full osteoarthritis therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

Which Region Currently Holds The Largest Share Of The Osteoarthritis Therapeutics Market?

North America was the largest region in the osteoarthritis therapeutics market in 2025. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Osteoarthritis Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19634&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Therapeutics Market 2026, By The Business Research Company

Axial Spondyloarthritis Axspa Global Market Report

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Gouty Arthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoporosis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795